Skip to content

Valerio Ricci

35 papers in the library · 143 citations · publishing 2010-2026

Papers

Sort Most recent Most cited

The Resurgence of Exogenous Psychosis: A Phenomenological Examination of Substance-Induced Psychopathology.

The Journal of Nervous and Mental Disease September 1, 2024 Valerio Ricci, Giuseppe Maina, Gilberto Di Petta et al.

The psychopathological manifestations associated with substance use, including induced psychotic experiences, are increasingly relevant but not well-understood within the medical community. Novel psychoactive substances and potentiated old compounds like cannabis and cocaine have emerged as a global concern, especially among adolescents and young adults. Transition rates from substance-induced...

Neurotrophic Factors in Cannabis-induced Psychosis: An Update

Current Topics in Medicinal Chemistry August 1, 2024 Valerio Ricci, Domenico de Berardis, Giovanni Martinotti et al.

Background: Cannabis is the most widely used illicit substance. Numerous scientific evidence confirm the strong association between cannabis and psychosis. Exposure to cannabis can induce the development of psychosis and schizophrenia in vulnerable individuals. However, the neurobiological processes underlying this relationship are unknown. Neurotrophins are a class of proteins that serve as...

Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review.

Healthcare January 29, 2024 Valerio Ricci, Domenico de Berardis, Giuseppe Maina 16 citations

This narrative review explores the efficacy and tolerability of third-generation antipsychotics (TGAs)-aripiprazole, cariprazine, brexpiprazole, and lurasidone-for the management of substance-induced psychosis (SIP). SIP is a psychiatric condition triggered by substance misuse or withdrawal, characterized by unique features distinct from those of primary psychotic disorders. These distinctive...

DOI: 10.3390/healthcare12030339 (opens in new tab) Full text (opens in new tab) Brexpiprazole Cariprazine Lurasidone Psychostimulants +7

Aberrant salience in cannabis-induced psychosis: a comparative study

Frontiers in Psychiatry January 8, 2024 Valerio Ricci, Ilenia di Muzio, Franca Ceci et al.

Background Natural Cannabis (NC) and Synthetic Cannabinoids (SCs) use can increase the risk and exacerbate the course of psychotic disorders. These could be influenced by the Aberrant Salience (AS) construct. It refers to an excess of attribution of meaning to stimuli that are otherwise regarded as neutral, thereby transform them into adverse, dangerous, or mysterious entities. This leads the...

Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview.

Psychopathology 2024 Valerio Ricci, Giuseppe Maina, Giovanni Martinotti 11 citations

The term "dissociation" encompasses a wide array of symptoms and phenomena, all sharing the common characteristic of involving altered states of consciousness where an individual temporarily loses the sense of continuity of their own identity. In the context of addiction pathology, however, the dissociative paradigm remains a topic of ongoing debate. It fluctuates between the description of...

The Loss of Spatiality and Temporality in Twilight Consciousness: The Emergence of Exogenous Psychosis Induced by Novel Psychoactive Substances.

Psychopathology 2024 Valerio Ricci, Giuseppe Maina, Giovanni Martinotti 8 citations

The state of twilight consciousness is marked by a focused narrowing of awareness, maintaining vigilance and attention while simultaneously experiencing perceptual shifts in the surrounding environment. It is crucial to recognize that this twilight state represents not just a contraction but also an expansion of conscious experience. Substances of abuse, particularly new psychoactive...

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals

EClinicalMedicine September 8, 2023 Mathilde Argote, Guillaume Sescousse, Jérôme Brunelin et al. 31 citations

Background: The association between cannabis use and positive symptoms in schizophrenia spectrum disorders is well documented, especially via meta-analyses. Yet, findings are inconsistent regarding negative symptoms, while other dimensions such as disorganization, depression, and excitement, have not been investigated. In addition, meta-analyses use aggregated data discarding important...

Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms

International Journal of Environmental Research and Public Health November 30, 2021 Valerio Ricci, Giovanni Martinotti, Franca Ceci et al. 33 citations

BACKGROUND: The Duration of Untreated Psychosis (DUP) is the time between the first-episode psychosis (FEP) and the initiation of antipsychotic treatment. It is an important predictor of several disease-related outcomes in psychotic disorders. The aim of this manuscript is investigating the influence of cannabis on the DUP and its clinical correlates. METHODS: During years 2014-2019, sixty-two...

Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.

Drug and Alcohol Dependence October 1, 2021 Valerio Ricci, Franca Ceci, Francesco di Carlo et al.

BACKGROUND Cannabis is the most used recreational drug worldwide. Its use can increase the risk of developing psychotic disorders and exacerbate their course. However, the relationship between cannabis use and dissociative symptoms has been scarcely investigated. AIMS To examine differences in psychotic and dissociative symptoms, and in functioning in first-episode psychotic patients (FEPp)...

Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms.

Addiction Biology July 2010 Francesco Angelucci, Valerio Ricci, Giovanni Martinotti et al.

The recreational drug 'ecstasy'[3,4-methylenedioxymethamphetamine (MDMA)] exerts a potent action on central serotonergic and dopaminergic neurons. These neurons utilize neurotrophins for their survival and function. In order to explore MDMA effects on neurotrophins, we measured by enzyme-linked immunosorbent assay the serum levels of brain-derived neurotrophic factor (BDNF) and nerve growth...